Literature DB >> 12073075

Modelling the economic impact of managing a chronic anal fissure with a proprietary formulation of nitroglycerin (Rectogesic) compared to lateral internal sphincterotomy in the United Kingdom.

Angela Christie1, Julian F Guest.   

Abstract

BACKGROUND AND AIMS: This study estimated the economic impact of using a proprietary formulation of 0.2% nitroglycerin (GTN) ointment (Rectogesic) compared with lateral internal sphincterotomy in the treatment of a chronic anal fissure in the United Kingdom (UK), from the perspective of the National Health Service (NHS). PATIENTS AND METHODS: Clinical and surgical outcomes attributable to managing a chronic anal fissure were obtained from published literature, supplemented with information about resource utilisation derived from interviews with a panel of colorectal surgeons and general practitioners. Using this information, a decision tree modelling the management of a chronic anal fissure by a colorectal surgeon was constructed. Unit resource costs at 1999/2000 prices were applied to the resource utilisation estimates in the model to estimate the expected NHS cost of managing a chronic anal fissure. Consensus on the information contained within the model was reached at a meeting with an expert panel comprising five of the interviewees and one other colorectal surgeon.
RESULTS: The expected NHS cost of a colorectal surgeon initially managing a chronic anal fissure with GTN was estimated to be pound616, compared to pound840 when a lateral internal sphincterotomy is the first-line treatment. Moreover, the expected probability of successful healing following initial treatment with either intervention is 99-100%, taking into account all subsequent treatments.
CONCLUSION: The initial use of GTN compared to lateral internal sphincterotomy to treat a chronic anal fissure affords a potential cost reduction to the NHS of pound224 per patient without any loss in effectiveness. Hence, GTN is potentially a cost-effective first-line treatment strategy for the management of a chronic anal fissure.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12073075     DOI: 10.1007/s00384-001-0371-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  4 in total

1.  Combined approach in the treatment of chronic anal fissures.

Authors:  S Vershenya; J Klotz; A Joos; D Bussen; A Herold
Journal:  Updates Surg       Date:  2015-04-21

2.  Comparative study of glyceryl trinitrate ointment versus surgical management of chronic anal fissure.

Authors:  Leo Francis Tauro; Vittal V Shindhe; P Sathyamoorthy Aithala; John J S Martis; H Divakar Shenoy
Journal:  Indian J Surg       Date:  2011-05-08       Impact factor: 0.656

3.  Cost-saving effect of treatment algorithm for chronic anal fissure: a prospective analysis.

Authors:  Rahila Essani; Grant Sarkisyan; Robert W Beart; Glenn Ault; Petar Vukasin; Andreas M Kaiser
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

4.  Comparison of topical nifedipine with oral nifedipine for treatment of anal fissure: a randomized controlled trial.

Authors:  Farzaneh Golfam; Parisa Golfam; Babak Golfam; Puyan Pahlevani
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.